Arcellx, Inc. (ACLX) Financials
Stock symbol ACLX is outdated, potentially delisted? Maybe it is available on other exchange?
ACLX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 604.0 million | 201.6 million |
| Sept. 30, 2025 | 655.9 million | 215.1 million |
| June 30, 2025 | 619.1 million | 226.9 million |
| March 31, 2025 | 648.1 million | 231.2 million |
ACLX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | -58.9 million | 18.1 million |
| Sept. 30, 2025 | -49.5 million | 17.9 million |
| June 30, 2025 | -40.2 million | 18.1 million |
| March 31, 2025 | -63.9 million | 23.8 million |
ACLX Net Income
No data available :(
ACLX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 450.3 million | 44.3 million | 44.3 million |
| Sept. 30, 2025 | 461.4 million | 44.3 million | 51.8 million |
| June 30, 2025 | 453.1 million | - | 52.5 million |
| March 31, 2025 | 543.3 million | - | 53.2 million |
ACLX Shares Outstanding
ACLX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | 764000 | 34.1 million | 29.6 million | - |
| Sept. 30, 2025 | 296000 | 35.1 million | 31.6 million | - |
| June 30, 2025 | 487000 | 37.6 million | 28.7 million | - |
| March 31, 2025 | 780000 | 50.8 million | 26.2 million | - |
ACLX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | 1.7 million | 1.6 million |
| Sept. 30, 2025 | 4.9 million | 35.1 million |
| June 30, 2025 | 7.6 million | 1.6 million |
| March 31, 2025 | 8.1 million | - |
ACLX
Price: $115.07
52 week price:
Earnings Per Share: -4.07 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 6.7 billion